Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Fo...(tial risks and uncertainties include but...),Health

Date:12/2/2008

tial risks and uncertainties include, but are not limited to: potential difficulties that may be encountered in integrating the merged businesses; potential uncertainties regarding market acceptance of Life Technologies; Life Technologies' ability to protect its intellectual property rights; competitive responses to the merger; an economic downturn, including the deterioration in economic and market conditions currently being experienced; risks that revenues may be lower than expected; Life Technologies' ability to make accurate estimates and control costs; Life Technologies' and its partners' ability to bid on, win, perform and renew contracts and projects; the need to develop new products and adapt to significant technological change; exposure to environmental liabilities and litigation; liabilities for pending and future litigation; the impact of changes in laws and regulations; industry competition; Life Technologies' ability to attract and retain key employees; employee, agent or partner misconduct; risks associated with changes in equity-based compensation requirements; Life Technologies' leveraged position and ability to service debt; risks associated with international operations; third-party software risks; terrorist and natural disaster risks; anti-takeover risks and other factors; as well as other risks and uncertainties detailed from time to time in Life Technologies' Securities and Exchange Commission filings.

For Research Use Only. Not for use in diagnostic procedures.

Copyright 2008. Life Technologies Corporation. All rights reserved. Applied Biosystems is a registered trademark of Life Technologies or its subsidiaries in the US and/or certain other countries. API 3200 is a trademark of Applied Biosystems/MDS Analytical Technologies, the joint venture between Life Technologies and MDS Inc.

Read the full story at

Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. ITRAC on track and bridging gap between academic research and applied discovery
2. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
3. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
4. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
5. Open Biosystems Open Access RNAi Program Continues to Gain Momentum Worldwide
6. Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens
7. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
8. Leading the Way in Cosmetic Surgery Los Angeles Surgeon and Beauty Expert, Dr. Christine Petti Offers Minimally Invasive SmartLipo™ – The Smart Way to Lose Fat
9. Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008
10. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories